| Product Name | MF | CAS | Details |
|---|
| RSS0680 | C52H64N10O6S3 | 2769753-48-0 | Details |
| Brentuximab | 2088770-90-3 | Details |
| Moiramide B | C25H31N3O5 | 155233-31-1 | Details |
| AC 7739 | C18H21NO4.ClH | 162705-22-8 | Details |
| Glembatumumab vedotin | 1182215-65-1 | Details |
| Inotuzumab | 1660159-36-3 | Details |
| RSH-7 | C22H25FN8O | 2764609-97-2 | Details |
| NP10679 | C23H26F3N3O3 | 2914889-88-4 | Details |
| PARP1/2/TNKS1/2-IN-1 | C35H31FN6O5 | 2243453-32-7 | Details |
| Navamepent | C18H24O4 | 1251537-11-7 | Details |
| MitoSOX Red | C43H43IN3P | 1003197-00-9 | Details |
| PARP-2-IN-3 | C20H20ClN3O3 | 2915650-86-9 | Details |
| OTUB1/USP8-IN-1 | C22H16ClFN2O4 | 2858800-98-1 | Details |
| pCDPK1/TgCDPK1-IN-3 | C17H18N6 | 1092788-87-8 | Details |
| Sonepcizumab | 1031360-18-5 | Details |
| Binospirone | C20H26N2O4 | 102908-59-8 | Details |
| USP28-IN-3 | C23H20Cl2N2O3S | 2931509-14-5 | Details |
| GSK3-IN-3 | C24H35N3O4 | 331963-27-0 | Details |
| Simmitecan hydrochloride | C34H39ClN4O6 | 1247847-78-4 | Details |
| Pincainide | C16H24N2O | 83471-41-4 | Details |
| Clivatuzumab | 1622075-09-5 | Details |
| Xanthine oxidoreductase-IN-5 | C17H17N5O2 | 1026652-90-3 | Details |
| Sarizotan 2HCl | C22H22ClFN2O | 177976-12-4 | Details |
| PU.1-IN-1 | C18H22N2O2S | 873588-27-3 | Details |
| Ordesekimab | 879293-15-9 | Details |
| isomer-CM 352 | C24H29N3O6S | 1542205-84-4 | Details |
| SF-22 | C28H26N2O3S | 824981-55-7 | Details |
| SID-852843 | C17H15N3O5S | 909859-19-4 | Details |
| (R)-HH2853 | C31H36F3N7O3 | 2202678-06-4 | Details |
| 11β-HSD1 inibitor 19 | C19H16ClF4N3O2S | 946400-19-7 | Details |
| CYP1B1-IN-5 | C14H8INO2 | 176442-56-1 | Details |
| Kukoamine B mesylate | C29H46N4O9S | 1375179-86-4 | Details |
| CpG ODN 10101 | 1234402-77-7 | Details |
| Dersalazine | C35H32N6O4 | 188913-58-8 | Details |
| GSNKGAIIGLM(131602-53-4(free base)) | C45H81N13O14S | Details |
| (R)-Enitociclib | C19H18F2N4O2S | 1610408-96-2 | Details |
| AXL-IN-13 | C34H41FN6O5 | 2376928-82-2 | Details |
| Cynandione A | C16H14O6 | 168706-29-4 | Details |
| CYP4A11/CYP4F2-IN-1 | C15H15N3OS | 502654-40-2 | Details |
| PCSK9-IN-10 | C18H23N5O4 | 368434-98-4 | Details |
| Senktide acetate | Details |
| DATPT | C24H38N6O3.ClH | 2891582-75-3 | Details |
| p53 Activator 7 | C27H32F3N4OP | 2849340-59-4 | Details |
| TJ08 | C22H16FN3O4 | 2924274-19-9 | Details |
| Cibisatamab | 1855925-27-7 | Details |
| Larotinib | C24H26ClFN4O4 | 1438072-11-7 | Details |
| CIA-1 (Free base) | C17H19N3O2S | 452087-38-6 | Details |
| BMS-823778 | C18H18ClN3O | 1140897-32-0 | Details |
| Plogosertib | C34H48N8O3 | 1137212-79-3 | Details |
| NSC243928 mesylate | C22H21N3O3S.CH4O3S | 59988-01-1 | Details |
| SRI-42127 | C19H20N6O | 2727872-68-4 | Details |
| Nampt activator-2 | C17H15ClN4O3S | 2237268-90-3 | Details |
| hCAII-IN-9 | C15H16ClN3O5S2 | 2878477-18-8 | Details |
| PRMT6-IN-3 | C19H26N4O2S | 2890765-10-1 | Details |
| SOS1-IN-15 | C28H27F3N6O2 | 2793404-47-2 | Details |
| BPDA2 | C24H30O5 | 2907659-86-1 | Details |
| ZIM | C20H19N3O3 | 301298-87-3 | Details |
| [Sar1, Ile8]-Angiotensin II 3TFA | C46H73N13O10 | Details |
| [Leu5]-Enkephalin acetate(58822-25-6 free base) | C28H37N5O7 | Details |
| Zilovertamab | 1643432-38-5 | Details |
| TGFβ1-IN-3 | C23H30N4O5 | 2883813-58-7 | Details |
| DC-BPi-03 | C14H14N4O2S | 2758411-46-8 | Details |
| SFI003 | C19H17N5OS | 2361332-90-1 | Details |
| Turosteride | C27H45N3O3 | 137099-09-3 | Details |
| SMN-C2 | C24H27N5O2 | 1446311-56-3 | Details |
| PF-17 | C21H28N4O5S | 2697145-21-2 | Details |
| (R)-BI-2852 | C31 H28 N6 O2 | 2375482-49-6 | Details |
| ccc_R08 | C22H19ClO6 | 2919019-72-8 | Details |
| N 0861 | C13H17N5 | 141696-90-4 | Details |
| CLK8 | C29H26N2O6 | 898920-65-5 | Details |
| STING agonist-30 | C15H16N4O8 | 2951078-67-2 | Details |
| (S)-VU0637120 | C16H19N3O5S2 | 1175940-86-9 | Details |
| Dazostinag disodium | C21H23F2N8NaO10P2S2 | 2553413-93-5 | Details |
| DPTN dihydrochloride | C22H18N4OS.2ClH | 325767-87-1 | Details |
| STC314 | C13H25NaO32S7 | 186295-19-2 | Details |
| APOBEC3G-IN-1 | C15H11NO3 | 14261-92-8 | Details |
| Xanthine oxidoreductase-IN-3 | C14H10ClN5O | 651769-78-7 | Details |
| Akt3 degrader 1 | C53H72N8O4 | 2836342-69-7 | Details |
| Theralizumab | 906068-56-2 | Details |
| Atibeprone | C17H18N2O3S | 153420-96-3 | Details |
| ENT-C225 | C26H40N4O5 | 2919962-53-9 | Details |
| Endo-1,3-β-glucanase | 9025-37-0 | Details |
| (Rac)-SHIN2 | C23H26N4O3 | 2204289-53-0 | Details |
| PDCD4-IN-1 | C12H9BrClN3O | 494763-64-3 | Details |
| Nemazoline Free Base | C10H11Cl2N3 | 130759-56-7 | Details |
| JNJ-49095397 | C34H36N6O4 | 1220626-82-3 | Details |
| AUTAC1 | C44H63FN8O11S | 2241669-09-8 | Details |
| GRGDSPK acetate | 144027-77-0 | Details |
| GW297361 | C16H12N4O3S2 | 388627-21-2 | Details |
| TGFβ1-IN-2 | C23H30N4O4S | 2700263-58-5 | Details |
| MJN68390 | C24H28ClN3O3 | 1956368-39-0 | Details |
| R 59-022 hydrochloride | C27H27ClFN3OS | 93076-98-3 | Details |
| Myosin V-IN-1 | C29H26N6O3S | 1259177-59-7 | Details |
| CZL55 | C20H22N2O6 | 667408-87-9 | Details |
| Angiotensin 1/2 (1-9) TFA | Details |
| M3541 | C23H17FN6O2 | 1360628-91-6 | Details |
| ZEN-2759 | C17 H16 N2 O2 | 1616400-50-0 | Details |
| Ebaresdax hydrochloride | C12H15ClN2O3S | 1334385-87-3 | Details |
| Sarizotan HCl | C22H22ClFN2O | 195068-07-6 | Details |
| P 218 | C18H25ClN4O4 | 1142407-60-0 | Details |
| Product Total： Product Page： | ||||
| 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 | ||||